✦ LIBER ✦

Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?

✍ Scribed by GERRY C MACQUILLAN; XIANWA NIU; DAVID SPEERS; SUZANNE ENGLISH; GEORGE GARAS; GERRY B HARNETT; WILLIAM D REED; JANE E ALLAN; GARY P JEFFREY

Book ID: 108949764
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 94 KB
Volume: 19
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2003.03319.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequence heterogeneity of NS5A and core

Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy

✍ Ahmed El-Shamy; Ikuo Shoji; Takafumi Saito; Hisayoshi Watanabe; Yoshi-Hiro Ide; 📂 Article 📅 2011 🏛 Center for Academic Publications, Japan 🌐 English ⚖ 346 KB

Mutations of hepatitis C virus 1b NS5A 2

Mutations of hepatitis C virus 1b NS5A 2209–2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients

✍ Hafida Khorsi; Sandrine Castelain; Ann Wyseur; Jacques Izopet; Valérie Canva; An 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Mutations in the NS5A and E2-PePHD regio

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin

✍ Sheng-Shun Yang; Ming-Yang Lai; Ding-Shinn Chen; Gran-Hum Chen; Jia-Horng Kao 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

621 THE ROLE OF SUBSTITUTIONS IN THE COR

621 THE ROLE OF SUBSTITUTIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B ON RESPONSIVENESS TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY

✍ Y. Katano; M. Ishigami; I. Nakano; K. Hayashi; T. Honda; H. Goto 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Analysis of genotypes and amino acid res

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy

✍ M Kurosaki; N Enomoto; T Murakami; I Sakuma; Y Asahina; C Yamamoto; T Ikeda; S T 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

of patients with a high likelihood of response to IFN-b. In chronic hepatitis C virus (HCV) infection, geno-(HEPATOLOGY 1997;25:750-753.) types other than genotype 1b of HCV (HCV-1b) and low serum HCV-RNA levels are known to be associated with favorable outcome of interferon alfa (IFN-a) therapy. In